Biotronik Enters into Distribution Agreement with InfoBionics

Biotronik has become the exclusive US distributor for InfoBionic's MoMe Kardia external cardiac diagnostic monitor. The device benefits patients suspected of experiencing cardiac arrhythmias. “When we’re looking at partners - we’re asking ourselves - are these partners able to do the three main things that are important to us,” Rupa Basu, Senior Vice President of Marketing, Corporate Accounts and Strategy, at Biotronik, told MD+DI. “The first thing is, is it going to improve the patient’s experience of care. The second is, is this going to improve the health of the patient population, and at the same time is it going to reduce the per capita cost of healthcare.” She noted that the InfoBionic MoMe Kardia system checks meets all of these criteria. MoMe is designed to increase early detection and diagnosis of cardiac arrhythmias by providing physicians with the ability to access near real-time electrocardiographic data. Monitoring can also uncover patients at higher risk of sudden cardiac death. Hospitalizations and life-threatening cardiac events decrease with early diagnosis and treatment. MoMe creates access to information that enables intervention to prevent negative outcomes. Medication compliance can be identified and managed, symptoms can be correlated with rhythms, and triggers of cardiac events can be found by analyzing th...
Source: MDDI - Category: Medical Devices Authors: Tags: Business Cardiovascular Source Type: news